Truist Financial’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11M | Buy |
162,631
+50,484
| +45% | +$3.36M | 0.01% | 615 |
|
|
2026
Q1 | $7.04M | Buy |
112,147
+18,734
| +20% | +$1.3M | 0.01% | 722 |
|
|
2025
Q4 | $6.2M | Sell |
93,413
-154,509
| -62% | -$9.99M | 0.01% | 764 |
|
|
2025
Q3 | $16.7M | Buy |
247,922
+48,993
| +25% | +$3.88M | 0.02% | 458 |
|
|
2025
Q2 | $17.4M | Buy |
198,929
+48,763
| +32% | +$3.82M | 0.03% | 436 |
|
|
2025
Q1 | $10.3M | Sell |
150,166
-11,365
| -7% | -$927K | 0.02% | 554 |
|
|
2024
Q4 | $12.6M | Sell |
161,531
-5,787
| -3% | -$428K | 0.02% | 511 |
|
|
2024
Q3 | $11.2M | Buy |
167,318
+123,822
| +285% | +$10.2M | 0.02% | 550 |
|
|
2024
Q2 | $4.93M | Sell |
43,496
-8,261
| -16% | -$1.04M | 0.01% | 866 |
|
|
2024
Q1 | $7.18M | Sell |
51,757
-240
| -0.5% | -$30.2K | 0.01% | 747 |
|
|
2023
Q4 | $6.45M | Sell |
51,997
-24,088
| -32% | -$2.46M | 0.01% | 774 |
|
|
2023
Q3 | $7.1M | Sell |
76,085
-5,306
| -7% | -$598K | 0.01% | 711 |
|
|
2023
Q2 | $10.5M | Sell |
81,391
-6,258
| -7% | -$757K | 0.02% | 571 |
|
|
2023
Q1 | $10.2M | Sell |
87,649
-20,384
| -19% | -$2.28M | 0.02% | 590 |
|
|
2022
Q4 | $12.2M | Sell |
108,033
-7,004
| -6% | -$769K | 0.02% | 503 |
|
|
2022
Q3 | $9.27M | Buy |
115,037
+2,817
| +3% | +$239K | 0.02% | 578 |
|
|
2022
Q2 | $8.36M | Sell |
112,220
-1,156
| -1% | -$106K | 0.02% | 628 |
|
|
2022
Q1 | $14.5M | Buy |
113,376
+19,760
| +21% | +$2.16M | 0.02% | 524 |
|
|
2021
Q4 | $12.6M | Buy |
93,616
+1,828
| +2% | +$263K | 0.02% | 567 |
|
|
2021
Q3 | $12.5M | Buy |
91,788
+1,300
| +1% | +$164K | 0.02% | 558 |
|
|
2021
Q2 | $9.66M | Sell |
90,488
-616
| -0.7% | -$59.2K | 0.02% | 646 |
|
|
2021
Q1 | $8.19M | Buy |
91,104
+11,408
| +14% | +$1.07M | 0.01% | 670 |
|
|
2020
Q4 | $7.37M | Buy |
79,696
+2,468
| +3% | +$220K | 0.01% | 688 |
|
|
2020
Q3 | $7.96M | Buy |
77,228
+77,012
| +35,654% | +$8.05M | 0.02% | 612 |
|
|
2020
Q2 | $22K | Sell |
216
-69,600
| -100% | -$6.23M | ﹤0.01% | 2360 |
|
|
2020
Q1 | $4.7M | Buy |
69,816
+4,988
| +8% | +$310K | 0.01% | 697 |
|
|
2019
Q4 | $3.55M | Buy |
+64,828
| New | +$3.07M | 0.01% | 888 |
|
|
2017
Q3 | – | Sell |
-19,404
| Closed | -$355K | – | 803 |
|
|
2017
Q2 | $355K | Sell |
19,404
-156
| -0.8% | -$2.88K | 0.01% | 633 |
|
|
2017
Q1 | $414K | Buy |
19,560
+4,920
| +34% | +$96K | 0.01% | 608 |
|
|
2016
Q4 | $218K | Buy |
14,640
+4,380
| +43% | +$77.6K | ﹤0.01% | 774 |
|
|
2016
Q3 | $225K | Buy |
+10,260
| New | +$228K | ﹤0.01% | 758 |
|
Other funds holding DXCM
DCP
SIMG
Truist Financial's DXCM Position: Q2 2026 in Review
Truist Financial increased its DexCom (DXCM) stake by 45% in Q2 2026, buying an estimated $3.36M and bringing the position to 162,631 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #615.
Truist Financial first reported a position in DXCM in Q3 2016 and has held it in 31 quarters since. The position peaked at $17.4M in Q2 2025. 444 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Truist Financial held 162,631 shares of DexCom worth $11M as of Q2 2026.
- Truist Financial bought 50,484 DexCom shares in Q2 2026, an estimated $3.36M.
- DexCom made up 0.01% of Truist Financial's portfolio in Q2 2026, its #615 holding.
- Truist Financial first reported a position in DexCom in Q3 2016 and has held it in 31 quarters since.
- Truist Financial's DexCom position peaked at $17.4M in Q2 2025.
- 444 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.